Publication

929O_PR ICON8: A GCIG phase III randomised trial evaluating weekly dose- dense chemotherapy integration in first-line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: results of primary progression- free survival (PFS) analysis

Clamp, Andrew R
; 
McNeish, I
; 
Dean, A
; 
Gallardo, D
; 
Weon-Kim, J
; 
O'Donnell, D
; 
Hook, J
; 
Coyle, C
; 
Blagden, S
; 
Brenton, J
... show 9 more
Citations
Altmetric:
Abstract
Authors
Clamp, Andrew R
McNeish, I
Dean, A
Gallardo, D
Weon-Kim, J
O'Donnell, D
Hook, J
Coyle, C
Blagden, S
Brenton, J
Naik, R
Perren, T
Sundar, S
Cook, A
James, E
Swart, A
Stenning, S
Kaplan, R
Ledermann, J
Affiliation
Medical Oncology, The Christie NHS Foundation Trust and University of Manchester, Manchester, UK
Description
Date
2017-09
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
929O_PRICON8: A GCIG phase III randomised trial evaluating weekly dose- dense chemotherapy integration in first-line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: results of primary progression- free survival (PFS) analysis 2017, 28(suppl_5): Ann Oncol
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/620638
Embedded videos